8-K//Current report
PhaseBio Pharmaceuticals Inc 8-K
Accession 0001193125-24-201295
CIK 0001169245operating
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:02 PM ET
Size
2.4 MB
Accession
0001193125-24-201295
Documents
- 8-Kd878992d8k.htmPrimary
8-K
- EX-99.1d878992dex991.htm
EX-99.1
- EX-101.SCHphasq-20240726.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABphasq-20240726_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREphasq-20240726_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg878992dsp015.jpg
GRAPHIC
- GRAPHICg878992dsp016.jpg
GRAPHIC
- GRAPHICg878992dsp017.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-24-201295-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd878992d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001169245
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:02 PM ET
- Size
- 2.4 MB